APIs

APIs

APIs · 53 products

Active pharmaceutical ingredients (APIs) and peptides, ≥99% purity, supplied through audited partner plants. COA and MSDS available on request.

StructureCAS No.Product NameSub-categoryAssay
Abemaciclib, LY2835219 structure1231929-97-7Abemaciclib, LY2835219Anti-Cancer API99%
Acalabrutinib, ACP-196 structure1420477-60-6Acalabrutinib, ACP-196Anti-Cancer API99%
Afatinib Dimaleate structure850140-73-7Afatinib DimaleateAnti-Cancer API99%
Alectinib Hydrochloride structure1256589-74-8Alectinib HydrochlorideAnti-Cancer API99%
Axitinib structure319460-85-0AxitinibAnti-Cancer API99%
Cabozantinib Malate structure1140909-48-3Cabozantinib MalateAnti-Cancer API99%
Crizotinib structure877399-52-5CrizotinibAnti-Cancer API99%
Dacomitinib structure1110813-31-4DacomitinibAnti-Cancer API99%
Galunisertib structure700874-72-2GalunisertibAnti-Cancer API99%
Ibrutinib structure936563-96-1IbrutinibAnti-Cancer API99%
Larotrectinib Sulfate structure1223405-08-0Larotrectinib SulfateAnti-Cancer API99%
Lenvatinib Mesylate structure857890-39-2Lenvatinib MesylateAnti-Cancer API99%
Lorlatinib structure1454846-35-5LorlatinibAnti-Cancer API99%
Neratinib Maleate structure915942-22-2Neratinib MaleateAnti-Cancer API99%
Nintedanib Ethanesulfonate structure656247-18-6Nintedanib EthanesulfonateAnti-Cancer API99%
Niraparib structure1038915-60-4NiraparibAnti-Cancer API99%
Niraparib Tosylate Monohydrate structure1613220-15-7Niraparib Tosylate MonohydrateAnti-Cancer API99%
Olaparib structure763113-22-0OlaparibAnti-Cancer API99%
Osimertinib Mesylate structure1421373-66-1Osimertinib MesylateAnti-Cancer API99%
Pazopanib Hydrochloride structure635702-64-6Pazopanib HydrochlorideAnti-Cancer API99%
Ponatinib Hydrochloride structure1114544-31-8Ponatinib HydrochlorideAnti-Cancer API99%
Poziotinib structure1092364-38-9PoziotinibAnti-Cancer API99%
Regorafenib Hydrate structure1019206-88-2Regorafenib HydrateAnti-Cancer API99%
Ribociclib Succinate structure1374639-75-4Ribociclib SuccinateAnti-Cancer API99%
Ruxolitinib Phosphate structure1092939-17-7Ruxolitinib PhosphateAnti-Cancer API99%
Temozolomide structure85622-93-1TemozolomideAnti-Cancer API99%
Vandetanib structure443913-73-3VandetanibAnti-Cancer API99%
Veliparib structure912444-00-9VeliparibAnti-Cancer API99%
Veliparib dihydrochloride structure912445-05-7Veliparib dihydrochlorideAnti-Cancer API99%
Vemurafenib structure918504-65-1VemurafenibAnti-Cancer API99%
Alogliptin benzoate structure850649-62-6Alogliptin benzoateAnti-Diabetes API99%
Dapagliflozin structure461432-26-8DapagliflozinAnti-Diabetes API99%
Empagliflozin structure864070-44-0EmpagliflozinAnti-Diabetes API99%
Ertugliflozin L-Pyroglutamic Acid structure1210344-83-4Ertugliflozin L-Pyroglutamic AcidAnti-Diabetes API99%
Linagliptin structure668270-12-0LinagliptinAnti-Diabetes API99%
Sotagliflozin structure1018899-04-1SotagliflozinAnti-Diabetes API99%
Trelagliptin Succinate structure1029877-94-8Trelagliptin SuccinateAnti-Diabetes API99%
Glecaprevir structure1365970-03-1GlecaprevirAnti-Hepatitis API99%
Obeticholic Acid structure459789-99-2Obeticholic AcidAnti-Hepatitis API99%
Pibrentasvir structure1353900-92-1PibrentasvirAnti-Hepatitis API99%
Simeprevir Sodium structure1241946-89-3Simeprevir SodiumAnti-Hepatitis API99%
Sofosbuvir structure1190307-88-0SofosbuvirAnti-Hepatitis API99%
Tenofovir Alafenamide Fumarate structure1392275-56-7Tenofovir Alafenamide FumarateAnti-Hepatitis API99%
Velpatasvir structure1377049-84-7VelpatasvirAnti-Hepatitis API99%
Baricitinib structure1187594-09-7BaricitinibAnti-Rheumatism API99%
Methotrexate structure59-05-2MethotrexateAnti-Rheumatism API99%
Tofacitinib Citrate structure540737-29-9Tofacitinib CitrateAnti-Rheumatism API99%
Upadacitinib structure1310726-60-3UpadacitinibAnti-Rheumatism API99%
Atosiban Acetate structure90779-69-4Atosiban AcetatePeptides99%
Glutathione structure70-18-8GlutathionePeptides99%
Octreotide Acetate structure83150-76-9Octreotide AcetatePeptides99%
Plecanatide structure467426-54-6PlecanatidePeptides99%
Terlipressin Acetate structure14636-12-5Terlipressin AcetatePeptides99%
Quality & documentation — batch-specific COA with HPLC purity and impurity profile; chiral purity by chiral HPLC where stereocentres are defined; residual solvent and elemental impurity data against ICH Q3C/Q3D on request; structure confirmation by NMR and MS on first shipments; SDS in the language of your market with GHS classification.

Don’t see the API you need? We cover the wider Chinese API and peptide range on request — send the CAS number or INN and we will confirm availability, documentation and lead time.

Send your request